Scandinavian Biopharma announces that Morgan Hjorth has joined their team.

Morgan Hjorth recently graduate from Karolinska Institute and Royal Institute of Technology (KTH) with two bachelor’s degrees and one Master degree of Science in Medical Biotechnology Engineering.

“It feels great to be a part of Scandinavian Biopharma. It’s really motivating to work with the late phase development of a new ETEC vaccine which address an unmet medical need of children in low-middle income countries as well as in travellers,” says Morgan Hjorth, researcher at Scandinavian Biopharma.